Matthew Locke is a Principal Scientist in Non-Malignant Hematology at Roche, having previously served as a Senior Scientist at the same company from 2021 to 2023, focusing on coagulation biology and bleeding disorders R&D. Prior to joining Roche, Matthew held roles at the Medicines and Healthcare products Regulatory Agency as a Senior Scientist, where they led projects to establish WHO International Standards, and at Barts Cancer Institute as a Postdoctoral Research Fellow, developing drug repurposing screens for cancer treatments. Matthew's educational background includes a D.Phil in Pharmacology and a Master of Biochemistry from the University of Oxford.
This person is not in the org chart
This person is not in any teams
This person is not in any offices